該当箇所へ

 

 

 

 

Biopharma Discovery Problems. Solved.

Genedata Biologics® brings biotherapeutic research to the next level by integrating all discovery workflows and processes in a central, structured database. As the most widely adopted platform across the industry, it is used by big pharmas and biotechs around the globe to digitalize the discovery of biotherapeutics. 

Watch this three-minute video introducing the only platform that integrates and centrally manages all data across biopharma workflows and instruments, unleashing the power to digitally trace every molecule, sample, result, and process.

Built for Biopharma. Transforming Discovery Workflows.

Uniquely designed for biotherapeutic discovery, Genedata Biologics facilitates complex R&D processes by designing, tracking, testing, and assessing novel biotherapeutics in any format, including antibodies, bi- or multi-specifics, ADCs, novel scaffolds, therapeutic proteins, TCRs and CAR-T cells. Acting as a central end-to-end data backbone, Genedata Biologics integrates all R&D across biopharma workflows and automates lab instruments and robotics stations to enable true high-throughput processes. With a central, shared database, users at all levels of an organization have real-time access to all relevant data to enable data-driven decisions that empower R&D.

Vaccine Discovery

Designed to increase the efficiency and quality of vaccine discovery, the purpose-built, end-to-end enterprise platform supports the full discovery process and enables faster testing, simplified production, and reduced costs. In addition to classical vaccine R&D approaches, it supports novel vaccine technologies such as synthetic self-amplifying mRNA, which accelerates vaccine development by utilizing synthetic and cell-free processes. Genedata Biologics paves the way for the discovery of novel vaccines, even for antigens that are extremely difficult to produce and formulate.

Learn More

Our Customers

Customer Stories

MorphoSys Digitalizes Large-Molecule R&D

Two-minute video highlighting how Genedata's bulit-for-biologics platform is accelerating R&D at MorphoSys.

A Single Source of Truth for Biopharma Discovery Data

Three-minute video explaining how Crescendo Biologics uses Genedata as a central repository for their entire R&D operations.

Transforming Discovery Operations

Three-minute video highlighting how Genedata's enterprise platform has empowered R&D at global biopharma companies.

Kymab Automates Lab Operations with Genedata

30-second video showing direct two-way integration of high-throughput B-cell selection and screening robotics.

Case Studies

Pfizer Builds on the Genedata Biopharma E2E Workflow Platform

After conducting a thorough market evaluation to identify an off-the-shelf enterprise system for large-molecule discovery, Pfizer implemented Genedata Biologics as their central repository for their biologics discovery data, including screening, molecular biology, engineering, expression, purification, and analytics.

MorphoSys Accelerates Antibody R&D with Genedata Biologics

After a formal selection process, MorphoSys adopted Genedata Biologics as their enterprise workflow platform because Genedata Biologics is the only off-the-shelf platform uniquely built for biopharmaceutical R&D.

Immatics Digitalizes CGT Discovery with Genedata Biologics

Leveraging Genedata’s out-of-the-box functionality, Immatics is streamlining CGT processes and increasing R&D efficiency. Genedata's scientific consultants also helped to configure Immatics-specific CGT workflows and integrate laboratory instruments so rollout of the platform was straightforward – and fast.

Conference Presentations

More Customer Presentations

Genedata's customers at leading biopharmaceutical and biotech companies worldwide regularly present how Genedata Biologics is used to advance their R&D activities. Learn how Pfizer, Bayer, UCB, Takeda, AbbVie, GSK, Kymab, Sanofi and others are streamlining processes and increasing efficiency of their biotherapeutic discovery operations with the Genedata platform.
 

Learn More

Meet the Genedata Community

Genedata Biopharma Partner Symposium
March 23–24, 2022 | Basel, Switzerland

This unique interdisciplinary event at the interface between biopharma R&D and IT is your chance to learn how other companies have set up and are using Genedata platforms. Presentations and discussions will focus on innovative applications and new industry requirements, such as novel molecular formats (e.g., multispecifics, TCRs, and CARs), MS-based multi-attribute methods (MAM), NGS, molecular-based patient profiling, and increasing automation and standardization in biopharmaceutical R&D.

Learn More

   
 

Empower Your Biopharma Discovery Today

Request More Information